- September 27, 2022Briefly: 8th Circuit Introduces Quality Control Aid for Briefs
- In re Entresto (Sacubitril/Valsartan) Patent Litigation
- September 2022Greenwashing Litigation is Increasing
- September 2022Legal Strategies For ESG Initiatives
- Uber Company Systems Compromised by Widespread Cyber Hack
- US Averts Rail Workers Strike With Last-Minute Tentative Deal
- Bial-Portela & Ca. S.A. v. Alkem Labs. Ltd.
- Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
- Founder and Exec Chair John Foley Resigns From Struggling Peloton
- Patent Value: Scoring Patents Using Characteristics Of Patents In Litigation
- September 2022Update on Exactech Knee, Hip, and Ankle Implant Recall Lawsuit
- September 202215 Years Later: The I-35 Bridge Collapse and the Lessons Carried On
- ECB Goes Big on Rate Hike to Battle Eurozone Inflation
- Fed Primes Markets for 75bps Rate Hike As Inflation Fight Continues
- Juul Reaches Deal with States to Settle Teen Marketing Allegations for $438M
- September 2, 2022Trade Dress Through a Trial Lens: Six Strategy Tips For Litigants
- Markets Anxiously Watch Jobs Report Data for Clues About Next Fed Rate Hike
- Disney Likely to Launch Prime-Style Membership Program
- US Job Openings Hit 11.2M in July, Show Still-Strong Labor Market
- United Therapeutics Corp. v. Liquidia Technologies, Inc.
- CA Lawmakers Target Fast-Food Industry, Children’s Privacy In New Measures
- Third QuarterGenerically Speaking: A Hatch-Waxman Litigation Bulletin
- Financial World Anxiously Awaits Economic Guidance from Fed Chair’s Jackson Hole Address
- August 26, 2022Questions Remain on Computer Fraud Coverage For Phishing
- White House Unveils Student Loan Debt Relief Program
- Beware Arguments Based On Implicit Claim Constructions
- Twitter Whistleblower Accuses Company of Lying About Security Practices and Bots
- Markets Crash Out to Start Week While Awaiting Fed Guidance
- U.S. Existing Home Sales Drop for Sixth Straight Month
- Fed Minutes Show Central Bank Committed to Rate-Hiking Course
- Par Pharm., Inc. v. Eagle Pharms., Inc.
- Vifor Fresenius Medical Care Renal Pharma Ltd. v. Teva Pharms. USA, Inc.
- President Signs Wide-Ranging Inflation Reduction Act into Law
- Briefly: Line Dancing for Lawyers, Take 2
- Third Point Takes Stake in Disney, Pushes for ESPN Spinoff
- Chiesi USA, Inc. v. Aurobindo Pharma USA, Inc.
- Tris Pharma, Inc. v. Teva Pharms. USA, Inc.,
- Rivian, Facing Supply-Chain Woes, Posts Massive $1.7B Quarterly Loss
- CPI Report Shows Slowing Inflation, Boosts Markets
- Crypto Crash Takes $1B Bite Out of Coinbase in Q2
- Salix Pharms., Ltd. v. Norwich Pharms., Inc.
- SoftBank Hit With $20+ Billion Quarterly Loss as Tech Investments Falter
- All Eyes on July Jobs Report Following Fed Rate Hikes
- Walmart to Cut 200 Corporate Positions Following Lowered Profit Forecasts
- Robinhood Cuts Workforce by 23% to Counter Ill-Advised Expansion
- Opendoor to Pay $62 Million to Settle FTC Claims That It Misled Homeowners
- August 1, 2022Why Directors Need To Talk About Insolvency
- Fed Again Raises Rates 75 bps in Bid to Tame Inflation
- IMF Revises Outlook for Global Growth, Warns of Looming Recession
- Feds Propose $85M Settlement With Chicken Producers Over Alleged Harm to Workers
